Overview
Bosuvi 100 mg Tablets contain Bosutinib, a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia (CML). It works by blocking the abnormal BCR-ABL kinase enzyme that drives cancer cell growth in CML. Bosuvi is prescribed when other treatments fail or when the patient cannot tolerate first-line therapies. It targets cancer cells with minimal impact on normal cells, offering an advanced approach to leukemia management.





